Tryptamine derivatives as novel non-nucleosidic inhibitors against hepatitis B virus

Bioorganic & Medicinal Chemistry
2011.0

Abstract

A series of tryptamine derivatives were synthesized and evaluated for their anti-hepatitis B virus (HBV) activity and cytotoxicity in the HepG2.2.15 cell line. The preliminary SAR was discussed. Compounds 2e and 4a showed potent antiviral activity (IC(50)=0.4 and <1 μM, respectively) and low cytotoxicity (CC(50)=40.6 and >25 μM, respectively).

Knowledge Graph

Similar Paper

Tryptamine derivatives as novel non-nucleosidic inhibitors against hepatitis B virus
Bioorganic &amp; Medicinal Chemistry 2011.0
Design and synthesis of novel benzimidazole derivatives as inhibitors of hepatitis B virus
Bioorganic &amp; Medicinal Chemistry 2010.0
Synthesis and Anti-Hepatitis B Virus Activity of Novel Benzimidazole Derivatives
Journal of Medicinal Chemistry 2006.0
Identification of 1-isopropylsulfonyl-2-amine benzimidazoles as a new class of inhibitors of hepatitis B virus
European Journal of Medicinal Chemistry 2007.0
Synthesis and biological evaluation of 1H-benzimidazol-5-ols as potent HBV inhibitors
Bioorganic &amp; Medicinal Chemistry Letters 2010.0
Design, Synthesis, and Antihepatitis B Virus Activities of Novel 2-Pyridone Derivatives
Journal of Medicinal Chemistry 2010.0
Synthesis and anti-hepatitis B virus activities of Matijing-Su derivatives
Bioorganic &amp; Medicinal Chemistry 2009.0
Design, synthesis and primary biological evaluation of the novel 2-pyridone derivatives as potent non-nucleoside HBV inhibitors
European Journal of Medicinal Chemistry 2017.0
Structure–activity relationships study of 6-chloro-4-(2-chlorophenyl)-3-(2-hydroxyethyl) quinolin-2(1H)-one derivatives as novel non-nucleoside anti-hepatitis B virus agents
European Journal of Medicinal Chemistry 2011.0
Synthesis and antiviral activity of new acrylamide derivatives containing 1,2,3-thiadiazole as inhibitors of hepatitis B virus replication
European Journal of Medicinal Chemistry 2010.0